METALLOPROTEASES AND INHIBITORS EXPRESSION IN MYOCARDIUM UNDER ISCHEMIC CONDITIONS AFTER ALLOGENIC BIOMATERIAL INTRODUCTION

METALLOPROTEASES AND INHIBITORS EXPRESSION IN MYOCARDIUM UNDER ISCHEMIC CONDITIONS AFTER ALLOGENIC BIOMATERIAL INTRODUCTION

Aim. To assess the expression of ММР-9 and TIMP-2 after intramyocardial injection of the allogenic biomaterial (AB) into ischemized myocardium in rodents.Material and methods. One hundred Wistar rodents were used, who underwent ligation of coronary artery. The experiment group (n=50), together with...

Full description

Bibliographic Details
Main Authors:	A. I. Lebedeva, S. A. Muslimov, E. M. Gareev, S. V. Popov, S. A. Afanasyev, D. S. Кondratyeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-08-01
Series:	Российский кардиологический журнал
Subjects:	biomaterial alloplant myocardial infarction ммр-9 timp-2
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2844

Similar Items

Stimulation of autologous progenitorial and committed cells in ischemically damaged myocardium
by: A. I. Lebedeva, et al.
Published: (2018-12-01)

FUNCTIONAL STATE OF MYOCARDIUM AFTER APPLICATION OF A NON-CELLULAR ALLOGENIC MATERIAL FOR STIMULATION OF REGENERATION CAPACITY IN EXPERIMENTAL INFARCTION
by: S. A. Afanasiev, et al.
Published: (2018-04-01)

IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS WITH DIFFERENT CORNEAL DISORDERS TREATED BY LAMELLAR KERATOPLASTY BY MEANS OF A LLOPLANT BIOMATERIAL
by: R. Z. Kadyrov, et al.
Published: (2014-07-01)

Correction of cicatricial changes in subacute stage of myocardial infarction with using of dispersed allogenic biomaterial
by: A. I. Lebedeva, et al.
Published: (2019-08-01)

Predictive value of MMP-2, MMP-9, TIMP-1 in surgical treatment of localized renal cell cancer
by: A. I. Tarasenko, et al.
Published: (2021-06-01)

THE VALUES OF MATRIX METALLOPROTEASE-9 AND TISSUE METALLOPROTEASE INHIBITOR-1 IN ACUTE MYOCARDIAL INFARCTION WITH ANEURYSM FORMATION
by: A. V. Govorin, et al.
Published: (2014-07-01)

Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage
by: A. I. Lebedeva, et al.
Published: (2023-04-01)

Macrophages as homeostatic regulators in the ischemically damaged myocardium after use of allogenic biomaterial
by: A. I. Lebedeva, et al.
Published: (2020-04-01)

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium
by: Nora Bloise, et al.
Published: (2020-04-01)

Changes of exosomal matrix metalloproteinases level in colorectal cancer associated with sex and metabolic disturbance
by: N. V. Yunusova, et al.
Published: (2019-11-01)

Effect of intramyocardial allogenic biomaterial injection on angiogenesis and postischemic scar remodeling in rats
by: A. I. Lebedeva, et al.
Published: (2020-10-01)

CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
by: A. S. Vorobyev, et al.
Published: (2019-06-01)

Immunohistochemical features of the granulation tissue structure in the primary and secondary apical periodontitis.
by: P. I. Gritsenko, et al.
Published: (2015-03-01)

Impact of Biomaterials on Differentiation and Reprogramming Approaches for the Generation of Functional Cardiomyocytes
by: Camilla Paoletti, et al.
Published: (2018-08-01)

Prognostic value of matrix metalloproteinases and transforming growth factor – β in kidney cancer
by: A. I. Tarasenko, et al.
Published: (2022-06-01)

THE USE OF DIFFERENT DONOR MATERIALS IN KERATOPLASTY (LITERATURE REVIEW)
by: A. V. Kirillichev, et al.
Published: (2015-12-01)

The use of different donor materials in keratoplasty (literature review)
by: A.V. Kirillichev, et al.
Published: (2013-01-01)

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
by: Vineeta Sharma, et al.
Published: (2021-09-01)

Application of Biomaterials in Cardiac Repair and Regeneration
by: Zhi Cui, et al.
Published: (2016-03-01)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
by: Arleta Waszczykowska, et al.
Published: (2020-11-01)

How biomaterials can influence various cell types in the repair and regeneration of the heart after myocardial infarction
by: Zachary Lister, et al.
Published: (2016-07-01)

Matrix metalloprotease 9 and remodeling after myocardial infarction
by: M. G. Shurygin, et al.
Published: (2013-04-01)

Prevention of post-infarction cardiac remodeling after using the non-cellular biomaterial in the experiment
by: S. A. Afanasiev, et al.
Published: (2019-08-01)

Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
by: V. O. Shavrin, et al.
Published: (2020-08-01)

SURGICAL AND ENDOVASCULAR REVASCULARIZATION OF MYOCARDIUM IN MULTIVESSEL DISEASE
by: I. G. Gordeev, et al.
Published: (2016-02-01)

The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
by: Lubis B, et al.
Published: (2022-09-01)

Differences of Serum Ratio MMP-9/TIMP-1 in ST-Elevation Myocardial Infarction (STEMI) and Non ST-Elevation Acute Coronary Syndrome (NSTEACS)
by: Basuki Rahmat, et al.
Published: (2014-03-01)

Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study
by: Ebru Alp, et al.
Published: (2017-02-01)

Successful Surgical Treatment of Postinfarction Rupture of Left Ventricular Myocardium
by: M. K. Mazanov, et al.
Published: (2020-10-01)

Evaluation of stunned and infarcted canine myocardium by real time myocardial contrast echocardiography
by: P.M.M. Dourado, et al.
Published: (2003-11-01)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
by: Tita Husnitawati Madjid, et al.
Published: (2020-06-01)

Protective Effects of Circulating TIMP3 on Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study
by: Heng Chen, et al.
Published: (2022-08-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding
by: Donatella Pia Spanò, et al.
Published: (2022-02-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)

Dye-Mediated Photo-Oxidation Biomaterial Fixation: Analysis of Bioinductivity and Mechanical Properties of Bovine Pericardium for Use in Cardiac Surgery
by: Simranjit S. Pattar, et al.
Published: (2021-10-01)

The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges
by: Salvatore Costa, et al.
Published: (2022-07-01)

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain
by: Agnieszka Łukomska, et al.
Published: (2020-12-01)

NETWORK APPROACH TO ANALYSIS OF QUANTITATIVE TRAIT LOCI FOR TUMOR NECROSIS FACTOR (TNFα-863, TNFα-308, TNFα-238), VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF-2578, VEGF+936) AND MATRIX METALLOPROTEINASE (ММР2-1306, ММР3-1171, ММР9-1569) GENES IN AGERELATED MACULAR DEGENERATION
by: A. V. Shevchenko, et al.
Published: (2017-10-01)

Biomaterials-Mediated Tumor Infarction Therapy
by: Shizheng Tong, et al.
Published: (2022-06-01)